Welcome to The EPMA Hub – Your Digital Pharmacy Knowledge Base



Dose-Based vs Product-Based Prescribing

Introduction
In EPMA systems, medications can be prescribed using two conventions: dose-based or product-based.
Understanding the differences helps improve prescribing safety, efficiency, and clarity during transitions of care.

What is Dose-Based Prescribing?
Dose-based prescribing focuses on the required dose (e.g. "Paracetamol 1g QDS") without tying the order to a specific product. The system or pharmacist determines how to supply the dose, offering flexibility in product selection. It’s common in hospital/inpatient settings, where clinicians manage medicines on-site.
​
Pros:
-
Greater flexibility for administration (e.g. tablets or liquid)
-
Simplifies prescribing when dose is more important than form
-
Well-suited to clinical workflows in hospitals
​
Cons:
-
Requires conversion before dispensing
-
Less clear for patients
-
Can introduce inconsistency if not standardized

What is Product-Based Prescribing?
Product-based prescribing ties the order to a specific product (e.g. "Paracetamol 500mg tablets, take 2 QDS"). This format is standard in primary care/community settings, where clear instructions are needed for dispensing.
​
Pros:
-
Precise, patient-friendly instructions
-
Ready for dispensing without interpretation
-
Ideal for EPS and community pharmacy
​
Cons:
-
Less flexible if product is unavailable
-
Prescribers must choose the right formulation up front
-
May require rewriting if needs change

Key Differences
Dose-Based Prescribing
Common Setting: Hospitals
Focus: Dose amount
Flexibility: High
Patient Clarity: Lower
Dispensing Ready: No
Suitable for EPS: N0
​
Product-Based Prescribing
Common Setting: Primary Care
Focus: Specific product
Flexibility: Low
Patient Clarity: Higher
Dispensing Ready: Yes
Suitable for EPS: Yes

Practical Example
-
Dose-Based:
"Paracetamol 1g QDS"
→ system/admin decides form
​
-
Product-Based:
"Paracetamol 500mg tablets, 2 QDS"
→ clear, specific product
​
Both conventions are essential in different contexts. Understanding their strengths and limitations helps ensure safe prescribing and smooth transitions across care settings.

Summary
Understanding the difference between dose-based and product-based prescribing is key to safe, effective use of EPMA systems.
While hospitals benefit from the flexibility of dose-based orders, community settings rely on the clarity of product-based prescriptions.
Both have their place. What matters is using the right approach for the right context, and ensuring smooth translation between them during care transitions.​
​
Related Topics: